Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans by Myers, Rachel A. et al.
Further replication studies of the EVE
Consortium meta-analysis identifies 2
asthma risk loci in European Americans
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Myers, Rachel A., Blanca E. Himes, Christopher R. Gignoux, James
J. Yang, W. James Gauderman, Cristina Rebordosa, Jianming Xie,
et al. 2012. Further replication studies of the EVE Consortium
meta-analysis identifies 2 asthma risk loci in European Americans.
Journal of Allergy and Clinical Immunology 130, no. 6: 1294–1301.
doi:10.1016/j.jaci.2012.07.054.
Published Version doi:10.1016/j.jaci.2012.07.054
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27005776
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Open Access Policy Articles, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#OAP
Further Replication Studies of the EVE Consortium Meta-
Analysis Identifies Two Asthma Risk Loci in European
Americans
Rachel A. Myers, PhDa, Blanca E. Himes, PhDb, Christopher R. Gignoux, MSc, James J.
Yang, PhDd, W. James Gauderman, PhDe, Cristina Rebordosa, MDf, Jianming Xie, PhDa,g,
Dara G. Torgerson, PhDc, Albert M. Levin, PhDd, James Baurley, PhDe, Penelope E.
Graves, PhDf, Rasika A. Mathias, ScDh, Isabelle Romieu, MD, ScDi, Lindsey A. Roth, MAc,
David Conti, PhDe, Lydia Avila, MDj, Celeste Eng, BSc, Hita Vora, MSe, Michael A. LeNoir,
MDk, Manuel Soto-Quiros, PhDj, Jinghua Liu, PhDe, Juan C. Celedon, MD, PhDl, Harold J.
Farber, MDm, Rajesh Kumar, MD, MPHn, Pedro C. Avila, MDo, Kelley Meade, MDp, Denise
Serebrisky, MDq, Shannon Thyne, MDc, William Rodriguez-Cintron, MDr, Jose R.
Rodriguez-Santana, MDs, Luisa N. Borrell, DDS, PhDt, Robert F. Lemanske Jr., MDu,
Eugene R. Bleecker, MDv, Deborah A. Meyers, PhDv, Stephanie J. London, MD, PhDw,
Kathleen C. Barnes, PhDh, Benjamin A. Raby, MDb, Fernando D. Martinez, MDf, Frank D.
Gilliland, PhDe, L. Keoki Williams, MD, MPHx, Esteban G. Burchard, MD, MPHc,y, Scott T.
Weiss, MDb, Dan L. Nicolae, PhDa,z,*, and Carole Ober, PhDa,*
aDepartment of Human Genetics, University of Chicago, Chicago, USA
bChanning Laboratory, Department of Medicine, Harvard Medical School, Boston, USA
cDepartment of Medicine, University of California, San Francisco, San Francisco, USA
dDepartment of Public Health Services, Henry Ford Health System, Detroit, USA
eDepartment of Preventative Medicine, University of Southern California, Los Angeles, USA
fArizona Respiratory Center and BIO5 Institute, University of Arizona, Tucson, USA
gSchool of Biological Sciences and Medical Engineering, School of Biological Sciences and
Medical Engineering, Southeast University, Nanjing, China
hDepartment of Medicine, Johns Hopkins University, Baltimore, USA
iInstituto Nacional de Salud Publica, Mexico City, Mexico
jHospital Nacional de Niños, San Jose, Costa Rica
kBay Area Pediatrics, Oakland, USA
lDivision of Pediatric Pulmonology, University of Pittsburgh, Pittsburgh, USA
mSection of Pulmonology, Baylor College of Medicine, Houston, USA
nDivision of Allergy and Immunology, Children's Memorial Hospital, Chicago, USA
© 2012 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.
Corresponding Author: Carole Ober, 920 E 58th St, CLSC room 425, Chicago IL, 60637. Phone: (773) 834-0735, Fax: (773)
834-0505, c-ober@genetics.uchicago.edu.
*These authors contributed equally to this work.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
J Allergy Clin Immunol. Author manuscript; available in PMC 2013 December 01.
Published in final edited form as:
J Allergy Clin Immunol. 2012 December ; 130(6): 1294–1301. doi:10.1016/j.jaci.2012.07.054.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
oDepartment of Medicine, Northwestern University, Chicago, USA
pChildren's Hospital of Oakland, Oakland, USA
qJacobi Medical Center and Department of Pediatrics, Albert Einstein College of Medicine, Bronx,
USA
rVeterans Affairs Medical Center, San Juan, Puerto Rico
sCentro de Neumologia Pediatrica, San Juan, Puerto Rico
tDepartment of Health Sciences, Lehman College, City University of New York, New York, USA
uDepartment of Pediatrics, University of Wisconsin, Madison, USA
vCenter for Human Genomics, Wake Forest School of Medicine, Winston-Salem, USA
wNational Institute of Environmental Health Sciences, Research Triangle Park, USA
xCenter for Health Services Research, Department of Internal Medicine, Henry Ford Health
System, Detroit, USA
yDepartment of Bioengineering & Therapeutic Sciences, Department of Bioengineering &
Therapeutic Sciences, University of California, San Francisco, San Francisco
zDepartments of Medicine and Statistics, Departments of Medicine and Statistics, University of
Chicago, Chicago
Abstract
Background—Genome-wide association studies of asthma have implicated many genetic risk
factors, with well-replicated associations at approximately 10 loci that account for only a small
proportion of the genetic risk.
Objectives—We aimed to identify additional asthma risk loci by performing an extensive
replication study of the results from the EVE Consortium meta-analysis.
Methods—We selected 3186 SNPs for replication based on the p-values from the EVE
Consortium meta-analysis. These SNPs were genotyped in ethnically diverse replication samples
from nine different studies, totaling to 7202 cases, 6426 controls, and 507 case-parent trios.
Association analyses were conducted within each participating study and the resulting test
statistics were combined in a meta-analysis.
Results—Two novel associations were replicated in European Americans: rs1061477 in the
KLK3 gene on chromosome 19 (combined OR = 1.18; 95% CI 1.10 – 1.25) and rs9570077
(combined OR =1.20 95% CI 1.12–1.29) on chromosome 13q21. We could not replicate any
additional associations in the African American or Latino individuals.
Conclusions—This extended replication study identified two additional asthma risk loci in
populations of European descent. The absence of additional loci for African Americans and Latino
individuals highlights the difficulty in replicating associations in admixed populations.
Keywords
Asthma; genetic risk factors; meta-analysis; KLK3
Introduction
Asthma is a common and complex disease, affecting approximately 300 million people
worldwide (1). There is strong evidence for a genetic contribution to asthma risk, with
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heritability estimates ranging between 35% and 95% (2, 3) and many genetic associations
reported (reviewed in (4)). Two large meta-analyses by the GABRIEL (5) and EVE (6)
Consortia and many genome-wide association studies (7–13) for asthma have been reported
in the last five years. The meta-analysis by the GABRIEL Consortium focused on
populations of European ancestry and included twenty-three different studies from across
Europe and Canada. Their findings included associations in or near the genes IL1RL1-
IL1RL18, HLA-DQ, IL33, SMAD3, and GSDMA/GSDMB (17q21). Most of these loci had
been previously been implicated in asthma or asthma-related phenotypes (e.g., 17q21 (7),
HLA-DQ (14–16), IL33 (17), IL1RL1 (17, 18)). Most of these associations were also
observed in the EVE Consortium meta-analysis, which included both primary and
replication individuals from European American, African American and Latino populations.
The EVE Consortium study also reported associations with single nucleotide
polymorphisms (SNPs) near the TSLP gene, which was reported in a sub-analysis in
GABRIEL as well as in previous studies (12, 19), and identified a novel association among
African American individuals with SNPs in the PYHIN1 gene.
In the original EVE meta-analysis, we attempted replication of 13 SNPs from separate
regions. The selected SNPs had association (p-value < 10−6) in either one of the three ethnic
groups or in the combined sample. For the current study, we hypothesized that some SNPs
with larger association p-values might also represent true associations. To address this
possibility, we performed a deeper replication study of the results of the EVE meta-analysis.
To this end, we genotyped a panel of 3,186 candidate SNPs in a replication sample totaling
7,709 individuals comprising European American, African American, and Latino subjects
with asthma.
Methods
EVE Consortium Meta-Analysis (Primary Analysis)
The detailed methods for the EVE consortium meta-analysis were previously published (6).
Briefly, the EVE meta-analysis was comprised of 4,867 European Americans (1,486 cases,
1,539 controls, and 620 trios), 4,644 Latinos (606 cases, 792 controls, and 1,082 trios), and
3,447 African Americans (1,154 cases, 1,054 controls, and 413 trios). Two million HapMap
SNPs were either genotyped or imputed (20) and were analyzed for association with asthma.
The meta-analysis test statistic was a linear combination of normally distributed test
statistics weighted by the square root of the study sample size. Significance of the meta-
analysis test statistic was assessed using standard normal approximations. This analysis will
henceforth be referred to as the primary analysis.
SNP Selection
We selected SNPs for additional genotyping based on the results from the original EVE
meta-analysis (referred to here as the primary study. This include all SNPs with a p-value <
1×10−4 in any one group (i.e. European American, African American, or Latino American
individuals) or a p-value < 1×10−3 in the combined meta-analysis of the groups combined. A
less conservative p-value cut-off was used for the combined meta-analysis than the ethnic
specific analyses because the combined analysis was more powerful and showed a larger
number of small p-values than the ethnicity-specific analyses. We also genotyped an
additional 407 SNPs that were informative for determining genetic ancestry (i.e. ancestry
informative markers [AIMs]).
Subjects and Genotyping
Asthma cases, non-asthma controls, and asthma case-parent trios were recruited from
locations across North and Central America by the same investigators contributing samples
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to the primary analysis. Descriptions of the replication samples and ascertainment schemes
were previously reported (Supplemental Table 4 and Supplemental Note in reference (6)).
Genotyping was performed using a custom Illumina iSELECT array at the Southern
California Genotyping Consortium (SCGC) at the University of California – Los Angeles.
Statistical Analysis
Each EVE center performed quality control and association analyses on their own data sets,
using protocols identical to those used in the primary analysis (6). The description of each
center’s quality control and statistical analyses, including covariates, is presented in the
supplemental methods. A shared summary file for each replication study population
included SNP name, risk allele, alternative allele, risk allele frequency in cases, risk allele
frequency in controls, normal or chi-square distributed test statistic, p-value, odds ratio, and
the standard error of the log odds ratio. Test statistics were converted to a standard normal
distribution and all results were checked for consistent allelic directionality across all study
populations. The meta-analysis test statistics were calculated as a linear, weighted
combination of the individual study population test statistics. The weights (w) were a
function of sample size (N), proportion of cases (v), and allele frequency (p) and defined as:
 (21). P-values were obtained using standard normal approximations.
The combined odds ratios were calculated as a linear combination of log odds ratios with
weights proportional to the standard errors of the log odds ratios. All statistical analyses
were completed using the statistical software R.
Enrichment Analysis
We investigated whether or not there was an enrichment of small p-values at the 0.01 level
in each of the four meta-analyses,, one each in the European American, African American,
Latino, and combined sample. To do this analysis we first constructed a set of p-values that
are not correlated or in linkage disequilibrium (LD). For each analysis, we grouped SNPs
according to physical location in the genome. Then, for each group of SNPs, we constructed
a region-based p-value by taking the smallest p-value from the group of SNPs and
multiplied that p-value by the number of SNPs in the group. This resulted in a region-based
p-value that has two properties: 1) the region-based p-value is a conservative multiple
testing corrected p-value for all of the SNPs within each genomic region and 2) the region-
based p-values are independent of each other. A binomial test was used to ascertain
enrichments of small (< 0.01), independent, region-based p-values. The null hypothesis in
this test is the region-based p-values are uniformly distributed and we do not observe any
replications, where as the alternative hypothesis is there exist an excess of small region-
based p-values. The assumption in the binomial test is that the all of the region-based p-
values are independent of each other, whereas this assumption of independence would be
violated if the binomial test was applied to the unadjusted p-values
Results
Of the 5,560 SNPs selected for replication, 3,186 passed the Illumina array design and were
successfully genotyped in 7,202 cases, 6,426 controls, and 507 case-parent trios (Table I).
The 3,186 SNPs included 177 SNPs from the five genomic regions that were replicated in
our earlier study (6). The remaining 3,009 SNPs (listed in Table EI in the Online
Repository) were in 690 genomic regions that showed a signal of association in the primary
analysis: 128 SNPs in 68 regions in European Americans, 340 SNPs in 124 regions in
African Americans, 258 SNPs in 74 regions in Latinos, and 2,450 SNPs in 595 regions in
the combined sample. The SNPs and regions are not entirely mutually exclusive among the
ethnic groups, 167 SNPs overlapped between two or more of the samples. The average
power to replicate these SNPs was highest among African Americans and lowest in Latinos
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(see Table EII in the Online Repository). The Q-Q plots for the 177 SNPs from the five
previously replicated regions show substantial inflation of small p-values in the European
American, Latino American, and the combined samples, but not in the African American
samples (Figure E1A–D in the Online Repository). In contrast, the Q-Q plots (Figure 1A–D)
of p-values for the ethnicity-specific replications revealed an inflation of small p-values only
in the European Americans, but not in the in the African American, Latino American, or
combined replication samples.
A summary of the replication results is shown in Table II. SNPs selected for replication
based on a group-specific result in the primary meta-analysis were analyzed in their
respective replication samples (e.g. primary meta-analysis results seen in European
American individuals were analyzed in a European American replication population). In
European American individuals, we expected fewer than one of the 128 SNPs to have a p-
value < 0.001 by chance. We observed 2 SNPs with a p-value < 0.001 in these samples,
which is a significant enrichment after accounting for linkage disequilibrium (LD) among
SNPs (p-value = 0.031). Only one SNP had a p-value < 0.001 in the African American
individuals and in the combined sample, which does not represent a significant enrichment
of low p-values in either group. Finally, none of the 258 SNPs had a p-value < 0.001 in the
Latino American samples.
The SNPs with the most significant combined (primary + replication) p-values are shown in
Table III. The two most significant associations were in the European American sample,
with p-values < 0.001 and combined (primary + replication) p-values approaching genome-
wide levels of significance (2×10−8). The first replication is with rs1061477 with a
combined primary and replication p-value of 2.3 × 10−8 and a combined odds ratio of 1.18
(95% CI 1.10 – 1.25) (Figure 2A). This SNP is in an intron in the KLK3 gene (encoding
kallikrein-related serine peptidase 3) on chromosome 19q13 (Figure 2B). The second
replication is with rs9570077, with a combined p-value of 9.9 × 10−8 and combined odds
ratio of 1.20 (95% CI: 1.12–1.29) (Figure 3A). This SNP is located on chromosome 13q21,
approximately 420 kb downstream of the DIAPH3 gene, which encodes diaphanous
homolog 3 (Figure 3B). Finally, seven SNPs showed small p-values in both the primary
sample (p-value < 1×10-4) and the replication sample (p-value <0.01) but large combined p-
values, indicating that the associations were in opposite directions. One such SNP is
rs9891949 with a replication p-value = 0.005 and a primary p-value = 7.5 × 10−7 in
European Americans. The risk SNP differed between studies (combined OR = 1.00, 95% CI
= 0.94 – 1.07, Figure 4). This SNP is located on chromosome 17p13, 1 kb from the gene
AURKB which encodes serine/threonine-protein kinase auora-B.
Discussion
We report here two additional replicated associations with asthma in European Americans.
Despite using a conservative test for enrichment, we observed a significant excess of small
p-values in the European American replication samples. Two of the three SNPs match the
direction of association seen in the primary analysis.
One of the replicated SNPs, rs1061477, lies in the KLK3 gene on chromosome 19q13. This
region includes other genes in the kallikrein family and lies within a region that was
previously implicated in asthma and related phenotypes through linkage studies in European
and European American families (14, 22, 23). Although not previously considered as an
asthma candidate in this gene rich region on 19q13, the fine-scale resolution of GWAS
specifically localized a strong association signal to the KLK3 gene. KLK3 encodes PSA
(prostate specific antigen) which can invoke an immune response by inducing IFN-γ
(interferon gamma) secretion (24). IFN-γ secretion is a key immunomodulatory molecule in
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asthma pathogensis (25). KLK3 gene expression is highest in the prostate but at lower levels
in other tissues (26), including bronchial epithelium from individuals with asthma (27).
The second replicated association, rs9570077, is located at 13q21 and resides between two
pseudogenes, RPP40P2 and POLR3KP1. SNPs in this region show very little LD (r2 ≤
0.075) with SNPs around the closest gene, DIAPH3. The 13q21 region has also been
implicated in asthma through linkage analysis (28). It is possible that the associated region
encodes a long-range enhancer of DIAPH3 or another gene on chromosome 13q21.
In addition to the two replicated associations, seven SNPs had small p-values in both the
primary (p-value < 1 × 10−4) and replication (p-value < 0.01) studies, but associations were
in opposite directions. The most dramatic example of this was the associations with
rs9891949, located 1 kb from the AURKB gene on chromosome 17p13. The association
signals were strong in both the primary and replication studies; the combined p-value
ignoring association directionality = 5.8 ×10−8 in European Americans. However, the
combined p-value accounting for directionality = 0.316 in European Americans (Figure 4).
This type of association with opposite alleles associated in primary and replication samples
has been reported in other studies of asthma, where it has been attributed to a genotype-
environment interactions with maternal asthma status (15) or to differences in LD between
population groups (13). In our study, it is difficult to attribute this pattern to either
explanation because participants in the Children’s Health Study (CHS) in Los Angeles were
included in both the primary and replication samples, and opposite association patterns were
observed within this one study. There are no substantial differences between the CHS
children included in the primary vs. replication study. In particular, we ruled out differences
in sex ratios, ages of onset of asthma, and indicators of atopy between the European
American primary and replication samples that showed association with one allele vs. the
other (Table EIII in the Online Repository). Finally, it is possible that these seven
associations are purely chance occurrences resulting from random variation in association
signals. Thus, it remains to be determined whether the seven associations of this type
represent true associations with direction of effect determined by an as yet unknown variable
or if they are simply the result of random variation.
Notably, none of the associations were replicated in African Americans or Latinos. This
observation is surprising because the power to replicate the primary associations signals was
high in all populations, with greatest power in the African Americans and least in the
Latinos (Table EII). However, there was a wider range of power estimates in the Latinos and
African Americans compared to European Americans. The combination of the lowest
average power and increased range of power for the Latino sample may have contributed to
the lack of replication in that sample, but is less likely to have contributed to the lack of
replication in the African Americans because power was the highest in that group.
It is possible that the association signals observed in the primary analyses were more likely
to be false positive associations in the admixed individuals due to reduced accuracy of
imputation in these populations. In the primary analysis, we included samples that were
genotyped with different platforms (Affymetrix or Illumina) and on arrays with different
numbers of SNPs. To enable analyses with the most inclusive set of SNPs, each
participating center imputed all SNPs that were not present on their platform but present on
at least one of the other platforms. Thus, different SNPs were imputed in different samples,
although all imputations were referenced against HapMap release 21 samples. Whole
genome sequences were available for a subset of the European American (n = 21), African
American (n = 32), and Latino (n = 24) individuals from the primary samples, allowing us to
determine concordance rates between imputed genotypes and true genotypes. We observed
similar concordance rates (98%) in all three populations, suggesting that our ability to
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replicate associations was not influenced by ethnicity-based differences in imputation
accuracy.
To address the possibility that signal heterogeneity across the primary studies limited our
ability to replicate, we investigated a measure technical heterogeneity: the proportion of
variation in odds ratios attributed to signal heterogeneity rather than random chance (I2). In
all populations, the heterogeneity (I2) of the odds ratios is very low (<25%) (29), indicating
that most of the variation in odds ratio estimates is a result of random variation rather than
study based differences in effect sizes. Less than five percent of SNPs had I2 values
considered highly heterogeneous (>75%). Therefore, heterogeneity of the primary
association signals does not explain the lack of replication in the admixed samples.
Alternatively, the lack of replication in the non-European, admixed populations may have
been due to differences between the primary and replication samples. In particular,
differences in ancestry or patterns of linkage disequilibrium (LD) may be limiting
replication in these samples. For example, it is well known that asthma prevalences differs
within Latinos (30) with highest prevalence among Puerto Ricans and lowest among
Mexicans (31). Although both the primary and replication studies included Mexican
Americans and Puerto Rican Americans from the U.S., the primary study also included
subjects from Mexico City whereas the replication study included subjects from Costa Rica
and Honduras. Likewise, our ‘African ancestry’ group included individuals from Barbados
in the primary analysis whereas only African Americans were included in the replication
studies. Differences in global and local ancestry between these samples could have impacted
our ability to replicate associations, even after adjusting for global ancestry (32). In addition,
patterns of LD in admixed populations may also be an important factor, notably if the
original association signals at typed or imputed SNPs are due to LD with causal variation.
Additional studies in these populations may shed light on these possibilities.
In summary, we report two additional asthma risk loci in European Americans that represent
previously unknown genes or regions and possibly novel pathways of pathogenesis. While
the effects of genotypes at each locus on risk are small, we provide evidence for two new
asthma candidate regions where family-based studies previously showed evidence of
linkage. Further investigations are required to identify the specific causal variants and the
mechanism of the associations for KLK3 and the 13q21 locus. The lack of replication in the
African and Latino American populations suggests that additional strategies are warranted
when studying these groups (33). Careful attention to sample composition and recruitment
strategies, environmental risk factors, and admixture corrections may improve the
identification and replication of genetic risk factors for asthma in admixed populations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key Messages
• Variation in KLK3 and 13q21 show association with asthma in European
Americans.
• Replication in admixed populations such as African Americans and Latinos is
sensitive to genetic and technical heterogeneity.
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Figure 1.
Q-Q plots of the replication results. In each plot (A–D), the observed -log(p-value) is plotted
against the expected -log(p-value). A) The 128 SNPs selected for replication in the
European American samples, B) 340 SNPs selected for replication in the African
Americans, C), 258 SNPs selected for replication in the Latinos, and D) 2450 SNPs selected
for replication in all samples.
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Figure 2.
Results for rs1061477 in the KLK3 gene. A) Forest plot showing the odds ratios (OR) and
95% confidence intervals for all European American studies in the primary and replication
meta-analyses. Two European American studies included in the primary analysis (CARE
and CAMP) were family-based studies and did not report odds ratios; those studies are not
included in the figure. The R package meta was used for determining the combined OR and
rmeta was used to generate the plot. B) Regional plot of the European American association
p-values surrounding rs1061477. Diamond represents p-values for SNPs from the primary
study and circles represent the combined (primary + replication) p-values. SNPs are shaded
according to LD with the SNP rs1061477, red indicating high LD. The light blue line
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represents CEU 1000 genomes pilot recombination rates. This figure was generated using
SNAP (35, 36).
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Figure 3.
Results for rs9570077 on 13q21. A) Forest plot showing the odds ratios (OR) and 95%
confidence intervals for all European American studies in the primary and replication meta-
analyses. Two European American studies included in the primary analysis (CARE and
CAMP) were family-based studies and did not report odds ratios; those studies are not
included in the figure. The R package meta was used for determining the combined OR and
rmeta was used to generate the plot. B) Regional plot of the European American association
p-values surrounding rs9570077. Diamond represents p-values for SNPs from the primary
study and circles represent the combined (primary + replication) p-values. SNPs are shaded
according to LD with the SNP rs9570077, red indicating high LD. The light blue line
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represents CEU 1000 genomes pilot recombination rates. This figure was generated using
SNAP (35, 36).
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Figure 4.
Forest plot of rs9891949 near AURKB. The odds ratios (OR) and 95% confidence intervals
for all European American studies in the primary and replication meta-analyses. Two
European American studies included in the primary analysis (CARE and CAMP) were
family-based studies and did not report odds ratios; those studies are not included in the
figure.
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Table I
Sizes of the samples included in the EVE replication studies.
Sample* EVE Site N Cases N Controls N Trios
European American individuals
CARE Arizona NA NA 69
CHS USC 155 157 NA
COAST Chicago 174 188 NA
iCAP Harvard 2,690 2,166 NA
African American individuals
iCAP Harvard 613 1,460 NA
SAGE UCSF 755 494 NA
SAPPHIRE Henry Ford 1,163 250 NA
CHS USC 108 88 NA
Latino individuals
CARE Arizona NA NA 51
CHS USC 289 287 NA
Costa Rica Harvard NA NA 387
GALA2 UCSF 1,184 1,241 NA
HOLA UCSF 71 95 NA
*CARE - Childhood Asthma Research and Education, CHS - Children’s Health Study, COAST-Childhood Origins of Asthma, iCAP - The i2b2
Crimson Asthma Project, SAGE – The Study of African Americans, Asthma, Genes and Environment, SAPPHIRE- Study of Asthma Phenotypes
and Pharmacogenomic Interactions by Race-Ethnicity, Costa Rica- Genetics of Asthma in Costa Rica Study, GALA2-Genes-Environment and
Admixture in Latino Asthmatics, HOLA-Honduran Latino Asthma Study
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Table II
Enrichments of region-adjusted small P-values. Enrichment p-values, or the probability of observing X or
more regions with p-value < 0.01, was determined using a binomial test.
Study Group Number of
Region-Based
p-values <
0.01
Total
Number of
Regions
Studied
Enrichment
p-value
SNP Contributing to
Each Region-Based
p-value < 0.01
European American 3 68 0.031 rs1061477,
rs9570077,
rs2415036*
African American 1 124 0.71 rs8052139
Latino 1 74 0.52 rs17097180*
All samples 3 595 0.94 rs12734326,
rs984176,
rs11968112
*SNPs for which the risk allele differs between the primary and replication studies; these are not included in Table III.
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